Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center.

about

Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center.

Item

http://www.wikidata.org/entity/Q55326300

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pathological Margin Clearance ...... nd European Pancreatic Center.

@en

Pathological Margin Clearance ...... nd European Pancreatic Center.

@nl

type

Item

label

Pathological Margin Clearance ...... nd European Pancreatic Center.

@en

Pathological Margin Clearance ...... nd European Pancreatic Center.

@nl

prefLabel

Pathological Margin Clearance ...... nd European Pancreatic Center.

@en

Pathological Margin Clearance ...... nd European Pancreatic Center.

@nl

P1476

Pathological Margin Clearance ...... nd European Pancreatic Center.

@en

P2093

Gyulnara G Kasumova

http://www.w3.org/2001/XMLSchema#string

Jennifer F Tseng

http://www.w3.org/2001/XMLSchema#string

Joanne Verheij

http://www.w3.org/2001/XMLSchema#string

L Bengt van Rijssen

http://www.w3.org/2001/XMLSchema#string

Olivier R Busch

http://www.w3.org/2001/XMLSchema#string

Omidreza Tabatabaie

http://www.w3.org/2001/XMLSchema#string

Robert M Najarian

http://www.w3.org/2001/XMLSchema#string

Sing Chau Ng

http://www.w3.org/2001/XMLSchema#string

Stijn van Roessel

http://www.w3.org/2001/XMLSchema#string

Thomas M van Gulik

http://www.w3.org/2001/XMLSchema#string

P2860

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties.

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.

Adjuvant radiation therapy for pancreatic cancer: a review of the old and the new.

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.

Redefining resection margin status in pancreatic cancer

Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)

2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.

P2888

s10434-018-6467-9

P304

1760-1767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-018-6467-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc G Besselink

P577

2018-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103239334

http://www.w3.org/2001/XMLSchema#string

P698

29651577

http://www.w3.org/2001/XMLSchema#string

P921

pancreaticoduodenectomy

P932

5928169

http://www.w3.org/2001/XMLSchema#string